Ibex Technologies (TSXV:IBT) Net Income From Continuing Operations : C$3.98 Mil (TTM As of Jan. 2024)

View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Ibex Technologies's net income from continuing operations for the three months ended in Jan. 2024 was C$0.05 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jan. 2024 was C$3.98 Mil.

Ibex Technologies Net Income From Continuing Operations Historical Data

The historical data trend for Ibex Technologies's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Net Income From Continuing Operations Chart

Ibex Technologies Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Net Income From Continuing Operations

Get a 7-Day Free Trial

-1.27

0.97

0.76

1.67

3.89

Ibex Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Income From Continuing Operations	Get a 7-Day Free Trial															0.10	0.89	2.22	0.81	0.05

Ibex Technologies Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$3.98 Mil.

Ibex Technologies (TSXV:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

IBXNF:USA IBT:Germany

Address

5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7

Website

https://www.ibex.ca

Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines